Safety of a compression stocking for patients with chronic venous insufficiency (CVI) and peripheral artery disease (PAD).


Journal

Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG
ISSN: 1610-0387
Titre abrégé: J Dtsch Dermatol Ges
Pays: Germany
ID NLM: 101164708

Informations de publication

Date de publication:
Mar 2020
Historique:
received: 18 06 2019
accepted: 08 09 2019
pubmed: 27 2 2020
medline: 29 12 2020
entrez: 27 2 2020
Statut: ppublish

Résumé

With increasing age, it is increasingly common for patients to develop both chronic venous insufficiency (CVI) and peripheral artery disease (PAD). While there are special compression bandage systems commercially available for individuals thus affected, appropriate compression stockings have previously not been available. In the present study, we investigated the safety and effectiveness of a type of compression stocking specifically designed for this patient group (VenoTrain In a prospective case series, we included patients with both CVI (C3-C5 disease according to CEAP classification) and PAD (ankle-brachial index of < 0.9 and > 0.5; absolute ankle systolic pressure of > 60 mmHg). Primary outcome measures consisted of 1) safety in terms of PAD, as determined by measuring acral pressure using acral photoplethysmography (APPG), and 2) effectiveness in terms of CVI symptoms, as assessed by using a suitable questionnaire (VVSymQ). Fifty patients were evaluated (mean age: 67.1; mean ankle-brachial index: 0.75 ± 0.77). Fifteen patients had stage IIa PAD (according to Fontaine); 15, stage IIb; the remainder, stage I disease. Thirty-one patients had stage C3 CVI (according to CEAP classification); 16 patients, stage C4; and three patients, stage C5 disease. Immediately after donning the medical compression stocking, systolic arterial pressure in the big toe increased significantly (from 83.3 mmHg ± 27.6 mmHg to 90.8 mmHg ± 24.1 mmHg) (p = 0.026). The VVSymQ score dropped significantly from 5.0 ± 4.95 points to 1.4 ± 2.26 points (p < 0.001), thus reflecting an improvement in CVI symptoms. The compression stocking tested herein is safe for individuals with an ankle brachial index ≥ 0.5. Skin damage was not observed.

Sections du résumé

BACKGROUND BACKGROUND
With increasing age, it is increasingly common for patients to develop both chronic venous insufficiency (CVI) and peripheral artery disease (PAD). While there are special compression bandage systems commercially available for individuals thus affected, appropriate compression stockings have previously not been available. In the present study, we investigated the safety and effectiveness of a type of compression stocking specifically designed for this patient group (VenoTrain
PATIENTS AND METHODS METHODS
In a prospective case series, we included patients with both CVI (C3-C5 disease according to CEAP classification) and PAD (ankle-brachial index of < 0.9 and > 0.5; absolute ankle systolic pressure of > 60 mmHg). Primary outcome measures consisted of 1) safety in terms of PAD, as determined by measuring acral pressure using acral photoplethysmography (APPG), and 2) effectiveness in terms of CVI symptoms, as assessed by using a suitable questionnaire (VVSymQ).
RESULTS RESULTS
Fifty patients were evaluated (mean age: 67.1; mean ankle-brachial index: 0.75 ± 0.77). Fifteen patients had stage IIa PAD (according to Fontaine); 15, stage IIb; the remainder, stage I disease. Thirty-one patients had stage C3 CVI (according to CEAP classification); 16 patients, stage C4; and three patients, stage C5 disease. Immediately after donning the medical compression stocking, systolic arterial pressure in the big toe increased significantly (from 83.3 mmHg ± 27.6 mmHg to 90.8 mmHg ± 24.1 mmHg) (p = 0.026). The VVSymQ score dropped significantly from 5.0 ± 4.95 points to 1.4 ± 2.26 points (p < 0.001), thus reflecting an improvement in CVI symptoms.
CONCLUSIONS CONCLUSIONS
The compression stocking tested herein is safe for individuals with an ankle brachial index ≥ 0.5. Skin damage was not observed.

Identifiants

pubmed: 32100962
doi: 10.1111/ddg.14042
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

207-213

Informations de copyright

© 2020 The Authors. Journal der Deutschen Dermatologischen Gesellschaft published by John Wiley & Sons Ltd on behalf of Deutsche Dermatologische Gesellschaft.

Références

Rabe E, Pannier-Fischer F, Bromen K et al. Bonner Venenstudie der Deutschen Gesellschaft für Phlebologie. Epidemiologische Untersuchung zur Frage der Häufigkeit und Ausprägung von chronischen Venenkrankheiten in der städtischen und ländlichen Wohnbevölkerung. Phlebologie 2003; 32: 1-14.
Wienert V, Gerlach H, Gallenkemper G et al. Leitlinie Medizinischer Kompressionsstrumpf (MKS). Phlebologie 2006; 35(6): 315-20.
Mosti G, Iabichella ML, Partsch H. Compression therapy in mixed ulcers increases venous output and arterial perfusion. J Vasc Surg 2012; 55: 122-8.
Ladwig A, Haase H, Bichel J et al. Compression therapy of leg ulcers with PAOD. Phlebology 2014; 29(1 suppl): 7-12.
Reich-Schupke S, Stücker M (Hrsg.). Moderne Kompressionstherapie - ein praktischer Leitfaden. Köln: Viavital Verlag GmbH, 2013.
Mosti G, Partsch H. Is low compression pressure able to improve venous pumping function in patients with venous insufficiency? Phlebology 2010; 25(3): 145-50.
Stücker M, Rabe E. Evidenz der Kompressionstherapie unter besonderer Berücksichtigung der Kompressionsstrümpfe der Kompressionsklasse. I. Vasomed 2016; 1: 20-1
Paty J, Turner-Bowker DM, Elash CA et al. The VVSymQ® instrument: Use of a new patient-reported outcome measure for assessment of varicose vein symptoms. Phlebology 2016; 31(7): 481-8.
Settembre N, Kagayama T, Kauhanen P et al. The influence of heating on toe pressure in patients with peripheral arterial disease. Scand J Surg 2018; 107(1): 62-7.
Rabe E, Partsch H, Hafner J et al. Indications for medical compression stockings in venous and lymphatic disorders: An evidence-based consensus statement. Phlebology 2018; 33(3): 163-84.
Thomä HJ. Größensysteme: Serien- und Maßstrümpfe. In: Reich-Schupke S, Stücker M. Moderne Kompressionstherapie - ein praktischer Leitfaden. Köln: Viavital Verlag GmbH, 2013: 25-30.
Deutsche Gesellschaft für Phlebologie. S1-Leitlinie Intermittierende pneumatische Kompression (IPK, AIK) AWMF Registernummer 037-007 ICD 10. Stand Januar 2018. Available from https://www.awmf.org/uploads/tx_szleitlinien/037-007l_S1_Intermittierende-pneumatische-Kompression-IPK-AIK_2018-07.pdf [Last accessed November 8, 2019].
Alvarez OM, Wendelken ME, Markowitz L et al. Effect of high-pressure, intermittent pneumatic compression for the treatment of peripheral arterial disease and critical limb ischemia in patients without a surgical option. Wounds 2015; 27(11): 293-301.
Berni A, Tromba L, Falvo L et al. Randomized study on the effects of different strategies of intermittent pneumatic compression for lower limb claudication. G Chir 2009; 30(6-7): 269-73.
Chang ST, Hsu JT, Chu CM et al. Using intermittent pneumatic compression therapy to improve quality of life for symptomatic patients with infrapopliteal diffuse peripheral obstructive disease. Circ J 2012; 76(4): 971-6.
Delis KT, Nicolaides AN. Effect of intermittent pneumatic compression of foot and calf on walking distance, hemodynamics, and quality of life in patients with Alvarez arterial claudication: a prospective randomized controlled study with 1-year follow-up. Ann Surg 2005; 241(3): 431-41.
Delis KT, Nicolaides AN, Wolfe JH et al. Improving walking ability and ankle brachial pressure indices in symptomatic peripheral vascular disease with intermittent pneumatic foot compression: a prospective controlled study with one-year follow-up. J Vasc Surg 2000; 31(4): 650-61.
Kavros SJ, Delis KT, Turner NS et al. Improving limb salvage in critical ischemia with intermittent pneumatic compression: a controlled study with 18-month follow-up. J Vasc Surg 2008; 47(3): 543-9.
Labropoulos N, Leon LR, Bhatti A et al. Hemodynamic effects of intermittent pneumatic compression in patients with critical limb ischemia. J Vasc Surg 2005; 42(4): 710-6.
Ramaswami G, D’Ayala M, Hollier LH et al. Rapid foot and calf compression increases walking distance in patients with intermittent claudication: results of a randomized study. J Vasc Surg 2005; 41(5): 794-801.
Riccioni C, Sarcinella R, Palermo G et al. Evaluation of the efficacy of propionyl-L-carnitine versus pulsed muscular compressions in diabetic and non-diabetic patients affected by obliterating arteriopathy Leriche stage II. Int Angiol 2008; 27(3): 253-9.
Sultan S, Esan O, Fahy A. Nonoperative active management of critical limb ischemia: initial experience using a sequential compression biomechanical device for limb salvage. Vascular 2008; 16(3): 130-9.
Tawfick WA, Hamada N, Soylu E et al. Sequential compression biomechanical device versus primary amputation in patients with critical limb ischemia. Vasc Endovascular Surg 2013; 47(7): 532-9.
Zaki M, Elsherif M, Tawfick W et al. The role of sequential pneumatic compression in limb salvage in nonreconstructable critical limb ischemia. Eur J Vasc Endovasc Surg 2016; 51(4): 565-71.
Reich-Schupke S, Gahr M, Altmeyer P et al. Resting pressure exerted by round knitted moderate-compression stockings on the lower leg in clinical practice - results of an experimental study. Dermatol Surg 2009; 35(12): 1989-97.
Protz K, Heyer K, Dörler M et al. Compression therapy: scientific background and practical applications. J Dtsch Dermatol Ges 2014; 12(9): 794-801.
Wu SC, Crews RT, Najafi B et al. Safety and efficacy of mild compression (18-25 mmHg) therapy in patients with diabetes and lower extremity edema. J Diabetes Sci Technol 20121; 6(3): 641-7.

Auteurs

Markus Stücker (M)

Department of Dermatology, Venereology and Allergology, Center for Venous Diseases of the Departments of Dermatology and Surgery, Ruhr University of Bochum, Bochum, Germany.

Olivia Danneil (O)

Department of Dermatology, Venereology and Allergology, Center for Venous Diseases of the Departments of Dermatology and Surgery, Ruhr University of Bochum, Bochum, Germany.

Martin Dörler (M)

Department of Dermatology, Venereology and Allergology, Center for Venous Diseases of the Departments of Dermatology and Surgery, Ruhr University of Bochum, Bochum, Germany.

Maren Hoffmann (M)

Department of Dermatology, Venereology and Allergology, Center for Venous Diseases of the Departments of Dermatology and Surgery, Ruhr University of Bochum, Bochum, Germany.

Elena Kröger (E)

Department of Dermatology, Venereology and Allergology, Center for Venous Diseases of the Departments of Dermatology and Surgery, Ruhr University of Bochum, Bochum, Germany.

Stefanie Reich-Schupke (S)

Department of Dermatology, Venereology and Allergology, Center for Venous Diseases of the Departments of Dermatology and Surgery, Ruhr University of Bochum, Bochum, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH